This segment focuses on the research, development, manufacturing, and commercialization of traditional Chinese medicine (TCM) and modern pharmaceutical products. R&D activities include the development of herbal medicines, extracts, and concentrated granules, as well as chemical medicines and APIs. Technologies employed encompass advanced extraction techniques, formulation science, and quality control methodologies. The therapeutic areas covered include cardiovascular, gastrointestinal, and other areas where TCM has a strong tradition. The patient impact is significant, offering alternative and complementary treatments. Market positioning is strong in China, with increasing global expansion. Future opportunities lie in integrating TCM with modern medicine and expanding into new markets. Regulatory and clinical aspects involve compliance with Chinese and international standards, including clinical trials and FDA approvals where applicable. Partnerships with research institutions and healthcare providers are crucial for innovation and market access.

This segment encompasses the development, manufacturing, and distribution of healthcare products and medical devices. R&D activities include the formulation of health products, such as health supplements and cosmetic series products, including moisture lotions, creams, and face washes. The company also provides daily hygiene products, such as sanitary pads and soaps, and medical equipment, including massage devices. Technologies used include advanced manufacturing processes, quality control systems, and product design. The therapeutic areas covered include general health and wellness, with a focus on preventative care and lifestyle products. The patient impact is focused on improving overall health and well-being. Market positioning is strong in the Chinese market, with opportunities for expansion into international markets. Future opportunities include the development of innovative health products and devices, as well as the integration of digital health technologies. Regulatory and clinical aspects involve compliance with relevant health and safety regulations. Partnerships with distributors and retailers are key to market access.

This segment focuses on the research and development of biopharmaceutical products, including biological medicines. R&D activities include drug discovery, clinical trials, and the development of new therapeutic approaches. Technologies employed include advanced biotechnology, molecular biology, and clinical trial methodologies. The therapeutic areas covered include cardiovascular and other areas. The patient impact is significant, offering innovative treatments for various diseases. Market positioning is competitive, with opportunities for growth through strategic partnerships and expansion into new markets. Future opportunities include the development of novel biopharmaceutical products and the expansion of clinical trial programs. Regulatory and clinical aspects involve compliance with FDA and other regulatory bodies. Partnerships with research institutions and healthcare providers are crucial for innovation and market access.